Zai Lab hits the road for $150m ADS follow-on
Chinese biotechnology firm Zai Lab is tapping equity investors for around $150m, hitting the market with a follow-on sale of American Depository Shares (ADS).
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: